NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

National Institutes of Health · PA-27-100 · Deadline: April 5, 2027

Program-level history — this opportunity doesn't publish per-opportunity awards, so these numbers describe its parent program (CFDA 93.068, Chronic Diseases: Research, Control, and Prevention), not this competition alone. Labeled that way on purpose.

Program volume ~16 awards/yr

73 unique recipients in the sample; 7 repeat winners.

Actual award size (program) $1.2M median

range $73k – $27.3M

Listing summary

The Small Business Innovation Research (SBIR) program helps United States small business concerns (SBCs) bring scientific innovations to the marketplace. The SBIR program supports feasibility studies to later research and development (R&D) needed to develop a commercial product.

Eligibility: Small businesses · Categories: Health · official listing ↗

This is the free preview

The full brief adds winner tables, recipient breakdowns, the printable "prepared for your client" version, and CSV export — plus a matched-grants list for your client's profile. Client Packet $79 or Pro subscription →

Sources: NIH RePORTER (opportunity-exact) and USAspending (program-level), labeled per section. GrantsDue computes summaries only; verify anything critical against the originals. Methodology.